Hyper Corporation

Hyper Corporation Revenue per Share

The Revenue per Share of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is 2,587.94 KRW. In the previous year, Revenue per Share was 1,985.91 KRW — a change of 30.31% (higher).

Revenue per Share

2,587.94KRW

YoY

30.31%

Last updated:

Revenue per Share of Hyper Corporation is 2025 2,587.94 KRW. Revenue per Share of Hyper Corporation was 2024 1,985.91 KRW. It decreases by 30.31% higher compared to the previous year.

The Hyper Corporation Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2018
675.62 KRW
Jan 1, 2019
591.49 KRW
Jan 1, 2020
1,067.11 KRW
Jan 1, 2021
1,672.98 KRW
Jan 1, 2022
1,538.43 KRW
Jan 1, 2023
1,456.74 KRW
Jan 1, 2024
1,985.91 KRW
Jan 1, 2025
2,587.94 KRW
The Hyper Corporation Revenue per Share history
YEARRevenue per ShareYoY
2,587.94KRW+30.31%
1,985.91KRW+36.33%
1,456.74KRW-5.31%
1,538.43KRW-8.04%
1,672.98KRW+56.78%
1,067.11KRW+80.41%
591.49KRW-12.45%
675.62KRW-4.88%
710.29KRW+59.66%
444.88KRW+59.42%
279.06KRW+51.93%
183.68KRW-94.85%
3,566.23KRW-25.79%
4,805.68KRW+9.90%
4,372.59KRW+21.03%
3,612.77KRW+146.91%
1,463.20KRW+0.04%
1,462.68KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Revenue per Share of Hyper Corporation is 2,587.94 KRW in 2025.

Revenue per Share of Hyper Corporation changed from 1,985.91 KRW to 2,587.94 KRW, representing a 30.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hyper Corporation

All Key Metrics — Hyper Corporation